Agenda – 3rd Payer Partnership Forum

  • Day One
  • Healthcare Executive Think Tank
  • Day Two

Day One


8:45AM – 9:00AM

Chairperson’s Opening Remarks
Marie Sanchirico,, Medical Managed Care, SANOFI GENZYME

9:00AM – 9:45AM

Define Market Access As a Corporate Driver
Jim Coccia, Vice President, U.S. Market Access, TAKEDA

9:45AM – 10:30AM

Identify EU HTA Agencies’ Impact on U.S. Payers
Kris Thiruvillakkat, Director, Global Market Access Strategy, PFIZER

10:30AM – 11:00AM

Networking Break

11:00AM – 12:00PM

Uncover Best Practices in Value-Based Contracting to Ensure Success From Initiation to Execution and Evaluation

Marie Sanchirico, Director, Medical Managed Care,, SANOFI GENZYME

Fred Brownfield, Director, Pharma Innovative Contracting, HUMANA
Michael Ruiz, Vice President, Provider Relations, UCARE
Brian McGarry, Market President, AETNA
Pritpal Virdee, Senior Vice President and Chief Operating Officer, Senior Health Services, BLUE CROSS BLUE SHIELD MICHIGAN
Barrie Baker, M.D., MBA, Chief Medical Officer, TUFTS HEALTH PUBLIC PLANS
Jonathan Harding, M.D., Senior Medical Director, Senior Products Division, TUFTS HEALTH PLANS
John G. Lovelace, President, Government Programs and Individual Advantage, UPMC HEALTH PLAN

12:00PM – 1:00PM

Networking Lunch

1:00PM – 1:45PM

Uncover Best Practices for Innovative Contracting Between Pharma and Payers
Fred Brownfield, Director, Pharma Innovative Contracting, HUMANA

1:45PM – 2:30PM

Case Study: Abbott Nutrition’s Collaboration With Advocate Health Care From a Health Economics Perspective
Jamie Partridge, Director, Global Scientific Affairs, ABBOTT

2:30PM – 3:15PM

Panel: Develop Value Propositions to Reflect Patient Needs
Sachin Kamal-Bahl, Vice President and Innovation Center Head, Global Health and Value, PFIZER

3:15PM – 3:45PM

Networking Break

4:30PM – 5:15PM

Utilize RWE to Define Value in Rare Diseases
Michele Cole, Director, Health Economics and Outcomes Research, ACTELION

Healthcare Executive Think Tank


5:30PM – 7:00PM


7:00PM –


As the healthcare landscape continues to drastically change and health systems continue to grow and consolidate to form large Accountable Care Organizations (ACOs) and Integrated Delivery Networks (IDNs), manufacturers are tasked with learning how to best contract with these expanding systems to ensure product success. With conflict of interest policies in place and restricted access to physicians, manufacturers need to change their sales approach.

This dinner panel is a unique opportunity to explore the needs of top ACO and IDN leaders in order to ensure you both thrive in the rapidly changing healthcare environment.

Day Two


8:30AM – 9:00AM

Continental Breakfast

9:00AM – 9:15AM

Chairperson’s Recap of Day One
Marie Sanchirico, Medical Managed Care, SANOFI GENZYME

9:15AM – 10:15AM

Define Strategies to Advance the Common Political and Structural Ground to Act As One Integrated Industry Instead of Insurers, Providers, and Pharma
Jeffrey Gold, Senior Vice President and Special Counsel, HEALTH ASSOCIATION OF NEW YORK STATE

10:15AM – 11:00AM

Considerations and Strategies in Developing Outcomes- Based Contracts
Josh Plumb, Senior Director, Payer Marketing, INTARCIA THERAPEUTICS

11:00AM – 11:30AM

Networking Break

11:30AM – 12:15PM

Examine What Is Right and What Is Wrong With Prescription Drug Pricing, Cost and Affordability in the United States
Robert Popovian, Pharm.D., Vice President, U.S. Government Relations, PFIZER

12:15PM – 1:15PM


1:15PM – 2:00PM

Use Real-World Evidence to Define and Demonstrate the Value Proposition
Anita Burrell, Adjunct Professor, RUTGERS UNIVERSITY

2:45PM – 3:30PM

From the Outside Looking In: A New Product Planning Perspective at Reimbursement and Pricing Early in Drug Development
Charles Pak, Senior Director, New Product Planning, IMMUNOGEN, INC.

3:30PM – 3:45PM

Chairperson’s Closing Remarks
Marie Sanchirico, Medical Managed Care, SANOFI GENZYME

3:45PM –

Forum Concludes